GeneQuine Adds World Renowned Osteoarthritis Key Opinion Leader Prof. Yves Henrotin to Advisory Board [ 13 Jan 2020 ]

GeneQuine Biotherapeutics, a biotech company developing gene therapy for osteoarthritis and other musculoskeletal disorders, is pleased to name the internationally recognized osteoarthritis key opinion leader Prof. Yves Henrotin as a new member of the advisory board.